Back to Results

Synergy CHC Corp (SNYR)

Synergy CHC Corp is a consumer products company focused on health care, beauty, and lifestyle brands in the United States, Canada, and the United Kingdom. Its product lineup includes FOCUSfactor brain health nutritional supplements, Flat Tummy wellness and accessory products, Hand MD hand care items, Perfekt Beauty cosmetics, Sneaky Vaunt shapewear and intimate apparel, The Queen Pegasus eyelash enhancement products, Neuragen topical treatments for neuropathic pain, and UrgentRx over-the-counter medications. The company distributes its products through club, mass drug, and other retail channels. Synergy CHC Corp was incorporated in 2010, is based in Westbrook, Maine, and adopted its current name in August 2015 after previously operating as Synergy Strips Corp.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-SNYR
$0.24
30.7% Upside
Undervalued
$3.75 1,983.3% Upside
—
Bargain
Weak
—
—
—
0.0%
August 13, 2026
-0.2x
-0.1x
0.1x
2.759 M
30.139 M
90.7%
54.8%
-14.4
—
24.1%
Send a message
Valuation • Fair Value

Synergy CHC Corp (NASDAQ-SNYR) Fair Value by Valuation Model

Compare the primary fair value estimate for Synergy CHC Corp (NASDAQ-SNYR) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.24

Estimated upside of 30.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.33

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.20

Comparable-company valuation reference.

Analyst Price Target

$3.75 1,983.3% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use this section to compare the primary fair value estimate for Synergy CHC Corp (NASDAQ-SNYR) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Synergy CHC Corp (NASDAQ-SNYR)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

27.703 M

Current operating scale indicator.

Revenue Forecast

31.502 M

Forward revenue estimate.

EBITDA

-10.84 M

Current operating profitability reference.

EBITDA Forecast

4.06 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Synergy CHC Corp (NASDAQ-SNYR) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Synergy CHC Corp (NASDAQ-SNYR)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-12.44

No elevated caution signal from this screen.

Altman Z-Score

-14.4

Lower score that deserves closer risk review.

FCF / Net Income

24.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Synergy CHC Corp (NASDAQ-SNYR). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Synergy CHC Corp (NASDAQ-SNYR)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 13, 2026

Days to Earnings

23

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Synergy CHC Corp (NASDAQ-SNYR), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Synergy CHC Corp (NASDAQ-SNYR) Stock Forecast & Technical Outlook

Review Synergy CHC Corp (NASDAQ-SNYR) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Synergy CHC Corp (NASDAQ-SNYR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Synergy CHC Corp (NASDAQ-SNYR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Synergy CHC Corp (NASDAQ-SNYR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Synergy CHC Corp (NASDAQ-SNYR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Synergy CHC Corp (NASDAQ-SNYR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Synergy CHC Corp (NASDAQ-SNYR)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Synergy CHC Corp (NASDAQ-SNYR) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ • Fast Investor Answers

Synergy CHC Corp (NASDAQ-SNYR) Stock FAQ

Quick answers about Synergy CHC Corp (NASDAQ-SNYR) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.24
Estimated upside 30.7%
Valuation Rating
Undervalued
Estimated upside of 30.7%
Analyst Target
$3.75 1,983.3% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Synergy CHC Corp (NASDAQ-SNYR) is $0.24. This implies an estimated upside of 30.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 30.7% versus the current market price.

The available analyst price target for Synergy CHC Corp (NASDAQ-SNYR) is $3.75 1,983.3% Upside.

The current financial health read for Synergy CHC Corp (NASDAQ-SNYR) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Synergy CHC Corp (NASDAQ-SNYR) is August 13, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Synergy CHC Corp (NASDAQ-SNYR) is -0.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Synergy CHC Corp is 2.759 M.

The current enterprise value listed for Synergy CHC Corp is 30.139 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Synergy CHC Corp is NASDAQ-SNYR, and the stock is listed on NASDAQ.

Synergy CHC Corp (NASDAQ-SNYR) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Synergy CHC Corp is 90.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Synergy CHC Corp is 54.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Personal Care Products Stocks on NASDAQ View more

Inter Parfums Inc (IPAR) Inter Parfums Inc (IPAR)
Olaplex Holdings Inc (OLPX) Olaplex Holdings Inc (OLPX)
Oddity Tech Ltd (ODD) Oddity Tech Ltd (ODD)
Honest Company Inc (HNST) Honest Company Inc (HNST)
Natures Sunshine Products Inc (NATR) Natures Sunshine Products Inc (NATR)
Niagen Bioscience Inc (NAGE) Niagen Bioscience Inc (NAGE)
Waldencast Acquisition Corp (WALD) Waldencast Acquisition Corp (WALD)
Empro Group (EMPG) Empro Group (EMPG)
FitLife Brands Inc (FTLF) FitLife Brands Inc (FTLF)
Beauty Health Co (SKIN) Beauty Health Co (SKIN)
Lifevantage Corporation (LFVN) Lifevantage Corporation (LFVN)
Bioharvest Sciences Inc (BHST) Bioharvest Sciences Inc (BHST)
Upexi Inc (UPXI) Upexi Inc (UPXI)
United-Guardian Inc (UG) United-Guardian Inc (UG)
Natural Health Trend (NHTC) Natural Health Trend (NHTC)
Natural Alternatives International (NAII) Natural Alternatives International (NAII)
Caring Brands Inc (CABR) Caring Brands Inc (CABR)
Big Tree Cloud Holdings Ltd (DSY) Big Tree Cloud Holdings Ltd (DSY)
Bonk Inc (BNKK) Bonk Inc (BNKK)
Mannatech Incorporated (MTEX) Mannatech Incorporated (MTEX)
PMGC Holdings Inc (ELAB) PMGC Holdings Inc (ELAB)
Paranovus Entertainment Technology Ltd (PAVS) Paranovus Entertainment Technology Ltd (PAVS)